van Gassel, Rob J. J.
Bels, Julia L. M. http://orcid.org/0000-0001-9190-1661
Tartaglia, Katrien
van Bussel, Bas C. T.
van Kuijk, Sander M. J.
Deane, Adam M.
Puthucheary, Zudin
Weijs, Peter J. M.
Vloet, Lilian
Beishuizen, Bert
De Bie Dekker, Ashley
Fraipont, Vincent
Lamote, Stoffel
Ledoux, Didier
Scheeren, Clarissa
De Waele, Elisabeth
van Zanten, Arthur R. H.
Mesotten, Dieter
van de Poll, Marcel C. G.
Funding for this research was provided by:
Belgian Health Care Knowledge Centre
ZonMw
Article History
Received: 24 March 2023
Accepted: 16 May 2023
First Online: 19 June 2023
Declarations
:
: The study protocol, consent forms and relevant documentation were approved by the Medical Ethics committee of Maastricht University (METC azM/MUMC + , METC20-039) and Leading Ethical Committee of the University Hospital of Brussels (2020/223). The trial is preregistered on ClinicalTrials.gov (identifier NCT04633421). Written informed consent will be obtained from participants and/or their legal representative according to the informed consent procedure detailed in the protocol.Patient representatives were involved in the design of our research and are also represented in the trial steering committee.
: Model consent forms for study participation for patient and for patient’s proxy, both in Dutch and in French, will be made available on request.<b>Competing interests {28}</b>ZP has received honoraria for consultancy from Nestle, Nutricia, Faraday Pharmaceuticals, and Fresenius-Kabi and speaker fees from Baxter, Fresenius-Kabi, Nutricia, and Nestle. No other potential competing interest was reported by the authors.